August 5, 2024 02:51 PM EDT
Deals

Mallinck­rodt sells pho­to­phere­sis plat­form Ther­akos for $925M

Nicole DeFeudis

Editor

Less than a year af­ter emerg­ing from its sec­ond bank­rupt­cy, Mallinck­rodt is sell­ing its pho­to­phere­sis plat­form Ther­akos to help pay off debt …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Ex­clu­sive: A male con­tra­cep­tive may pre­vent 99% of preg­nan­cies. Now it’s up to a small biotech to fin­ish test­ing it

Sanofi, Re­gen­eron to re­file Dupix­ent for skin con­di­tion af­ter new study win

Bridge­Bio ends de­vel­op­ment of gene ther­a­py for adren­al gland dis­or­der

GSK to shut down UK an­tibi­ot­ic fa­cil­i­ty fol­low­ing end of San­doz con­tract

Roche's dual GLP-1/GIP re­sults show promis­ing weight loss, but al­so high rates of vom­it­ing

Gilead part­ners with AI start­up Gen­e­sis Ther­a­peu­tics to make small mol­e­cule drugs

A service from the Financial Times